Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis

Clinical trial NCT03283917 · COMPLETED

Trial details

NCT number: NCT03283917
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Newly Diagnosed Primary Amyloidosis Recurrent Primary Amyloidosis Refractory Primary Amyloidosis

Start date: 2018-02-07
Primary completion: 2026-06-17
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.